Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
mfERG_LAB: Software for processing multifocal electroretinography signals.
Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients.
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory Diseases
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Corticosteroids for treating optic neuritis.
Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)
On dihydroorotate dehydrogenases, their inhibitors and uses.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
Symptom overlap in anxiety and multiple sclerosis.
Physical Activity Behavior Change in Persons With Neurologic Disorders: Overview and Examples From Parkinson Disease and Multiple Sclerosis.
Comment on the letter by Messori et al. (European Journal of Neurology 2013; 20: e131).
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Pages
« first
‹ previous
…
157
158
159
160
161
162
163
164
165
…
next ›
last »